Correlation Between Travere Therapeutics and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Legend Biotech Corp, you can compare the effects of market volatilities on Travere Therapeutics and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Legend Biotech.
Diversification Opportunities for Travere Therapeutics and Legend Biotech
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Travere and Legend is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Legend Biotech go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Legend Biotech
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 1.71 times more return on investment than Legend Biotech. However, Travere Therapeutics is 1.71 times more volatile than Legend Biotech Corp. It trades about 0.03 of its potential returns per unit of risk. Legend Biotech Corp is currently generating about -0.04 per unit of risk. If you would invest 1,667 in Travere Therapeutics on August 31, 2024 and sell it today you would earn a total of 214.00 from holding Travere Therapeutics or generate 12.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Travere Therapeutics vs. Legend Biotech Corp
Performance |
Timeline |
Travere Therapeutics |
Legend Biotech Corp |
Travere Therapeutics and Legend Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Travere Therapeutics and Legend Biotech
The main advantage of trading using opposite Travere Therapeutics and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |